Recombinant Human SYTL2 Protein，His

SYTL2 (Syntaxin-1A- and Syntaxin-3-binding protein 2) belongs to the synaptotagmin-like protein family and plays a vital role in cellular processes, particularly in membrane trafficking and cytoskeletal organization. This protein is primarily expressed in neuronal tissues, suggesting its involvement in synaptic function and neurotransmitter release. Recent studies indicate that SYTL2 may act as a mediator in the transport of vesicles along the actin filaments, crucial for the dynamic processes of synaptic vesicle cycling. Dysregulation of SYTL2 has been associated with various neurological disorders, including neurodegenerative diseases and synaptopathies, highlighting its potential as a therapeutic target. The characterization of SYTL2 as a recombinant protein is pivotal for understanding its structural and functional properties, enabling researchers to investigate its interactions with other cellular components. In vitro studies using SYTL2 recombinantly expressed in suitable systems allow for detailed analysis of its binding affinities and mechanisms of action, which are essential for elucidating its role in neuronal communication and plasticity. As research continues to unveil the intricate network of protein interactions in the nervous system, SYTL2 stands out as a candidate worth exploring further, offering insights into both basic neurobiology and potential intervention strategies for synaptic dysfunction.